The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.
Open accessAbstract
Increased expression of wild-type p53 in response to DNA damage arrests cells late in the G1 stage of the cell cycle by stimulating the synthesis of inhibitors of cyclin-dependent kinases, such as p21/WAF1. To study the effects of p53 without the complication of DNA damage, we used tetracycline to regulate its expression in MDAH041 human fibroblasts that lack endogenous p53. When p53 is expressed at a level comparable to that induced by DNA damage in other cells, most MDAH041 cells arrested in G1, but a significant fraction also arrested in G2/M. Cells released from a mimosine block early in S phase stopped predominantly in G2/M in the presence of p53, confirming that p53 can mediate arrest at this stage, as well as in G1. In these cells, there was appreciable induction of p21/WAF1. MDAH041 cells arrested by tetracycline-regulated p53 for as long as 20 days resumed growth when the p53 level was lowered, in striking contrast to the irreversible arrest mediated by DNA damage. Therefore, irreversible arrest must involve processes other than or in addition to the interaction of p53-induced p21/WAF1 with G1 and G2 cyclin-dependent kinases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“P53 uses cell cycle checkpoints to induce G1/S142, 143 and G2/M cell cycle arrest.144”
From Census and evaluation of p53 target genes (2017) · cites this paper as [144]
Citations
Cites
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,318
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
Lowe, S. W., Ruley, H. E., Jacks, T., & Housman, D. E. (1993) · Cell · doi:10.1016/0092-8674(93)90719-7 · Cited by 2,911
Cited by
Sorted by citations
Items 301–400 of 856
Urban, G., Golden, T. A., Aragon, I. V., Cowsert, L. M., Cooper, S. R., Dean, N. M., & Honkanen, R. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210993200 · Cited by 51
p53 Suppression of Arsenite-Induced Mitotic Catastrophe Is Mediated by p21CIP1/WAF1
Taylor, B. F., McNeely, S., Miller, H. L., Lehmann, G. M., McCabe, M. J., & States, J. C. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.103077 · Cited by 51
Wang, Z., Su, Z.-Z., Fisher, P. B., Wang, S., VanTuyle, G., & Grant, S. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4191 · Cited by 53
Saeed, M. E. M., Jacob, S., Sandjo, L. P., Sugimoto, Y., Khalid, H. E., Opatz, T., Thines, E., & Efferth, T. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00267 · Cited by 53
Pilot screening programme for small molecule activators of p53
Berkson, R., Hollick, J. J., Westwood, N. J., Woods, J. A., Lane, D. P., & Laı́n, S. (2005) · International Journal of Cancer · doi:10.1002/ijc.20968 · Cited by 52
A DNA damage signal is required for p53 to activate gadd45.
Xiao, G., Chicas, A., Olivier, M., Taya, Y., Tyagi, S., Kramer, F. R., & Bargonetti, J. (2000) · PubMed · Cited by 51
p53 Mutation and Mitotic Infidelity
Tarapore, P., & Fukasawa, K. (2000) · Cancer Investigation · doi:10.3109/07357900009038246 · Cited by 51
Histone methylation in the freeze-tolerant wood frog (Rana sylvatica)
Hawkins, L. J., & Storey, K. B. (2017) · Journal of Comparative Physiology B · doi:10.1007/s00360-017-1112-7 · Cited by 54
Modulation of Erythropoietin Delivery from Engineered Muscles in Mice
Bohl, D., & Heard, J. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.2-195 · Cited by 51
p53-Oriented cancer therapies: Current progress
Gallagher, W. M., & Brown, R. E. (1999) · Annals of Oncology · doi:10.1023/a:1008368500557 · Cited by 51
Chen, L., Liu, P., Chen, Y., Tseng, H., Shen, P.-C., Hwang, P., & Hsu, H.-L. (2017) · Scientific Reports · doi:10.1038/s41598-017-12111-1 · Cited by 50
Radiosensitivity and oxidative signalling in ataxia telangiectasia: an update
Lavin, M. F. (1998) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(98)00027-9 · Cited by 49
Eps8 decreases chemosensitivity and affects survival of cervical cancer patients
Chen, Y., Shen, M., Chen, Y.-J., Maa, M., & Leu, T. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2388 · Cited by 49
Elmegeed, G. A., Yahya, S. M. M., Abdelhalim, M. M., Mohamed, M. S., Mohareb, R. M., & Elsayed, G. H. (2016) · Steroids · doi:10.1016/j.steroids.2016.08.014 · Cited by 48
Ling, Z., Guan, H., You, Z., Wang, C., Hu, L., Zhang, L., Wang, Y., Chen, S., Xu, B., & Chen, M. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s165262 · Cited by 48
Davey, H. M., Jones, A., Shaw, A. D., & Kell, D. B. (1999) · Cytometry · doi:10.1002/(sici)1097-0320(19990201)35:2 · Cited by 56
Differential cell cycle checkpoint response in normal human keratinocytes and fibroblasts.
Flatt, P. M., Price, J. O., Shaw, A. T., & Pietenpol, J. A. (1998) · PubMed · Cited by 48
Perturbation of the p53 response by human papillomavirus type 16 E7
Hickman, E. S., Bates, S., & Vousden, K. H. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3710-3718.1997 · Cited by 47
Badie, C., Bourhis, J., Sobczak‐Thépot, J., Haddada, H., Chiron, M., Janicot, M., Janot, F., Tursz, T., & Vassal, G. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0976 · Cited by 47
Genetic and molecular alterations in pancreatic cancer: Implications for personalized medicine
Chen, C. (2013) · Medical Science Monitor · doi:10.12659/msm.889636 · Cited by 48
Valdez, B. C., Li, Y., Murray, D. L., Corn, P. G., Champlin, R. E., & Andersson, B. S. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.08.014 · Cited by 47
Patra, N., De, U., Kang, J., Kim, J. M., Ahn, M. Y., Lee, J., Jung, J. H., Chung, H. Y., Moon, H. R., & Kim, H. S. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.02.015 · Cited by 48
Eo, S.-H., Kim, J., & Kim, S. J. (2015) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504015x14298122915583 · Cited by 47
Baselet, B., Belmans, N., Coninx, E., Lowe, D., Janssen, A., Michaux, A., Tabury, K., Raj, K., Quintens, R., Benotmane, M. A., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00213 · Cited by 48
Moh, M. C., Zhang, T., Lee, L. H., & Shen, S. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn226 · Cited by 48
Molecular markers in clinical radiation oncology
Haffty, B. G., & Glazer, P. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206704 · Cited by 47
Selimović, D., El‐Khattouti, A., Ghozlan, H. A., Haïkel, Y., Abdel-Kader, O., & Hassan, M. (2012) · World Journal of Hepatology · doi:10.4254/wjh.v4.i12.342 · Cited by 46
Nigam, N., Prasad, S., George, J., & Shukla, Y. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.033 · Cited by 46
Ghate, N. B., Das, A. K., Chaudhuri, D., Panja, S., & Mandal, N. (2016) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.62 · Cited by 46
Cell‐cycle regulation of the p53‐inducible gene B99
Collavin, L., Monte, M., Verardo, R., Pfleger, C. M., & Schneider, C. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01969-4 · Cited by 46
Yu, W., Chen, G., Zhang, P., & Chen, K. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.10.005 · Cited by 45
Expression and Role of p53 in the Retina
Vuong, L., Conley, S. M., & Al‐Ubaidi, M. R. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8909 · Cited by 45
Mosadegh, M., Hasanzadeh, S., & Razi, M. (2017) · PubMed Central · doi:10.22038/ijbms.2017.8249 · Cited by 45
Cell Cycle Aberrations in the Pathogenesis of Squamous Cell Carcinoma of the Uterine Cervix
Clarke, B. A., & Chetty, R. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6306 · Cited by 45
Sak, A., Wurm, R. E., Elo, B., Grehl, S., Pöttgen, C., Stüben, G., Sinn, B., Wolf, G., Budach, V., & Stuschke, M. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700649 · Cited by 45
Bishay, K., Ory, K., Lebeau, J., Levalois, C., Olivier, M., & Chevillard, S. (2000) · Oncogene · doi:10.1038/sj.onc.1203405 · Cited by 46
Bache, M., Pigorsch, S. U., Dunst, J., Würl, P., Meye, A., Bartel, F., Schmidt, H., Rath, F. W., & Taubert, H. W. (2001) · International Journal of Cancer · doi:10.1002/ijc.1002 · Cited by 45
Jones, J. M., Attardi, L. D., Godley, L. A., Laucirica, R., Medina, D., Jacks, T., VARMUS, H. E., & Donehower, L. A. (1997) · PubMed · Cited by 45
Antitumour potential of BPT: a dual inhibitor of cdk4 and tubulin polymerization
Mahale, S., Bharate, S. B., Manda, S., Joshi, P., Jenkins, P. R., Vishwakarma, R. A., & Chaudhuri, B. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.96 · Cited by 44
Dual Regulation of Cdc25A by Chk1 and p53-ATF3 in DNA Replication Checkpoint Control
Demidova, A. R., Aau, M. Y., Li, Z., & Yu, Q. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m808118200 · Cited by 43
Proliferation and survival of human amniotic epithelial cells during their hepatic differentiation
Maymó, J. L., Riedel, R. N., Pérez‐Pérez, A., Magatti, M., Maskin, B. C., Dueñas, J. L., Parolini, O., Sánchez‐Margalet, V., & Varone, C. L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191489 · Cited by 45
Huo, J., Metz, S. A., & Li, G. D. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401322 · Cited by 44
Yingying, X., Li, X., Wang, H., Wen, R., He, J., & Tang, J. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12597 · Cited by 43
Cell cycle progression and apoptosis after irradiation in an acidic environment
Park, H. J., Lyons, J., Ohtsubo, T., & Song, C. W. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400702 · Cited by 43
Is p53 Involved in Tissue‐Specific Insulin Resistance Formation?
Strycharz, J., Drzewoski, J., Szemraj, J., & Śliwińska, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9270549 · Cited by 45
RNA oxidation in chromatin modification and DNA-damage response following exposure to formaldehyde
Gonzalez‐Rivera, J. C., Sherman, M. W., Wang, D., Chuvalo-Abraham, J. C. L., Ruiz, L. H., & Contreras, L. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-73376-7 · Cited by 47
Pardo, F. S., Hsu, D., Zeheb, R., Efird, J. T., Okunieff, P. G., & Malkin, D. M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602161 · Cited by 43
Tang, X., Yano, T., Osuga, Y., Matsumi, H., Yano, N., Xu, J., Wada, O., Koga, K., Kugu, K., Tsutsumi, O., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.8.3721 · Cited by 43
Sirtuin1-p53: A potential axis for cancer therapy
Yin, J., Lu, X.-T., Hou, M.-L., Cao, T., & Tian, Z. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115543 · Cited by 44
Brown, D., Lassegue, B. P., Lee, M., Zafari, R., Long, J. S., Saavedra, H. I., & Griendling, K. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096657 · Cited by 42
MAPK15 upregulation promotes cell proliferation and prevents DNA damage in male germ cell tumors
Rossi, M., Colecchia, D., Ilardi, G., Acunzo, M., Nigita, G., Sasdelli, F., Celetti, A., Strambi, A., Staibano, S., Croce, C. M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8044 · Cited by 42
AL-QUBAISI, M. S., Flaifel, M. H., Hussein‐Al‐Ali, S. H., Hussein, M. Z., Alhassan, F. H., Taufiq, Y. H. H., Eid, E. E. M., Arbab, I. A., Al-Asbahi, A. B., Webster, T. J., et al. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s50061 · Cited by 42
Składanowski, A., & Larsen, A. K. (1997) · PubMed · Cited by 42
Oncoprotein Signalling and Mitosis
Laird, A., & Shalloway, D. I. (1997) · Cellular Signalling · doi:10.1016/s0898-6568(96)00176-3 · Cited by 42
Low-Dose-Rate Radiation Attenuates the Response of the Tumor Suppressor TP53
Ohnishi, T., Wang, X., Takahashi, A., Ohnishi, K., & Ejima, Y. (1999) · Radiation Research · doi:10.2307/3579950 · Cited by 42
Chang, E. H., Jang, Y., Hao, Z., Murphy, G., Rait, A. S., Fee, W. E., Sussman, H. H., Ryan, P. C., Chiang, Y. L., & Pirollo, K. F. (1997) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1997.01900050055007 · Cited by 42
The Novel Function of OCT4B Isoform-265 in Genotoxic Stress
Gao, Y., Wei, J., Han, J., Wang, X., Su, G., Zhao, Y., Chen, B., Xiao, Z., Cao, J., & Dai, J. (2012) · Stem Cells · doi:10.1002/stem.1034 · Cited by 41
Ai, T.-J., Sun, J., Du, L., Shi, C., Li, C., Sun, X., Liu, Y., Li, L., Xia, Z., Jia, L., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.160 · Cited by 40
Moringa peregrina Leaves Extracts Induce Apoptosis and Cell Cycle Arrest of Hepatocellular Carcinoma
Mansour, M., Mohamed, M. F., Elhalwagi, A., El‐Itriby, H. A., Shawki, H. H., & Abdelhamid, I. A. (2019) · BioMed Research International · doi:10.1155/2019/2698570 · Cited by 41
Effects of Iron Ions, Protons and X Rays on Human Lens Cell Differentiation
Chang, P. Y., Bjornstad, K. A., Rosen, C. J., McNamara, M. P., Mancini, R., Goldstein, L. E., Chylack, L. T., & Blakely, E. A. (2005) · Radiation Research · doi:10.1667/rr3368.1 · Cited by 41
Apoptosis in Carcinogenesis and Chemotherapy
Chen, G. G., & Lai, P. B. S. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9597-9 · Cited by 49
A role for cadherins in cellular signaling and differentiation
Knudsen, K. A., Frankowski, C., Johnson, K. R., & Wheelock, M. J. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1998)72:30/31+ · Cited by 88
Broselid, S., Cheng, B., Sjöström, M., Lövgren, K., Santiago, H. L. P. K.-D., Belting, M., Jirström, K., Malmström, P., Olde, B., Bendahl, P., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2376 · Cited by 44
Vaibhav, J., Ray, P., Sachdeva, G., & Bhatt, P. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.042 · Cited by 40
Kinoshita, Y., Kalir, T., Rahaman, J., Dottino, P., & Kohtz, D. S. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.09.024 · Cited by 40
p53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints
Agapova, L. S., Ivanov, A., Sablina, A. A., Kopnin, P., Oi, S., Chumakov, P. M., & Kopnin, B. P. (1999) · Oncogene · doi:10.1038/sj.onc.1202386 · Cited by 40
Lloyd, D. R., & Hanawalt, P. C. (2002) · PubMed · Cited by 39
Choene, M. S., & Motadi, L. R. (2016) · Molecular Biology · doi:10.1134/s0026893316010040 · Cited by 43
RetractedCao, C., Zhang, H., Zhao, L., Zhou, L.-X., Zhang, M., Xu, H. Z., Han, X., Li, G., Yang, X., & Jiang, Y. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.07.007 · Cited by 39
Chen, M., Chou, C.-H., Shun, C., Mao, T., Wen, W.-F., Chen, C., Chen, S., Yang, Y., & Ho, H. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox099 · Cited by 39
Kumar, R. J., Chao, H. X., Simpson, D. A., Feng, W., Cho, M.-G., Roberts, V., Sullivan, A. R., Shah, S., Wozny, A., Fagan‐Solis, K. D., et al. (2020) · NAR Cancer · doi:10.1093/narcan/zcaa038 · Cited by 38
Shan, B., Xu, J., Zhuo, Y., Morris, C. A., & Morris, G. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302671200 · Cited by 39
Luch, A., Kudla, K., Seidel, A., Doehmer, J., Greim, H. A., & Baird, W. M. (1999) · Carcinogenesis · doi:10.1093/carcin/20.5.859 · Cited by 39
Åmellem, Ø., Stokke, T., Sandvik, J. A., Smedshammer, L., & Pettersen, E. O. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3497 · Cited by 39
Suetens, A., Konings, K., Moreels, M., Quintens, R., Verslegers, M., Soors, E., Tabury, K., Grégoire, V., & Baatout, S. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00087 · Cited by 38
Berberine inhibits the proliferation of human uterine leiomyoma cells
Wu, H.-L., Chuang, T.-Y., Al-Hendy, A. A., Diamond, M. P., Azziz, R., & Chen, Y.-H. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.01.010 · Cited by 40
Lescarbeau, R. S., Lei, L., Bakken, K. K., Sims, P. A., Sarkaria, J. N., Canoll, P., & White, F. M. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0692 · Cited by 38
Proapoptotic p53-Interacting Protein 53BP2 Is Induced by UV Irradiation but Suppressed by p53
Lopez, C. D., Ao, Y., Rohde, L. H., Perez, T. D., O’Connor, D. J., Lü, X., Ford, J. M., & Naumovski, L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.21.8018-8025.2000 · Cited by 38
Chazal, M., Marionnet, C., Michel, L., Mollier, K., Dazard, J.-E., Della-Valle, V., Larsen, C., Gras, M.-P., & Basset‐Séguin, N. (2002) · Oncogene · doi:10.1038/sj.onc.1205349 · Cited by 39
Musk, A. W., de Klerk, N. H., Ambrosini, G. L., Eccles, J. L., Hansen, J., Olsen, N. J., Watts, V. L., Lund, H., Pang, S., Beilby, J. P., et al. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980130)75:3 · Cited by 77
Takahashi, M., Seki, N., Ozaki, T., Kato, M., Kuno, T., Nakagawa, T., Watanabe, K., Miyazaki, K., Ohira, M., Hayashi, S., et al. (2002) · PubMed · Cited by 38
Laverty, D. J., Gupta, S. K., Bradshaw, G. A., Hunter, A. S., Carlson, B. L., Calmo, N. M., Chen, J., Tian, S., Sarkaria, J. N., & Nagel, Z. D. (2024) · Nature Communications · doi:10.1038/s41467-024-49316-8 · Cited by 43
Sesamin inhibits cervical cancer cell proliferation by promoting p53/PTEN-mediated apoptosis
Kuo, T., Lin, C., Li, G.-D., Kuo, C., & Kao, S. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.48955 · Cited by 37
Tumor Suppressor SMAR1 Activates and Stabilizes p53 through Its Arginine-Serine-rich Motif
Jalota, A., Singh, K., Chavali, P. L., Kaul-Ghanekar, R., Jameel, S., & Chattopadhyay, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413200200 · Cited by 37
RetractedChondrogianni, N., Trougakos, I. P., Kletsas, D., Chen, Q. M., & Gonos, E. S. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00425.x · Cited by 36
Xiang, P., Liu, R.-Y., Sun, H., Yang, Y., Cui, X.-Y., & Ma, L. Q. (2017) · Environmental Research · doi:10.1016/j.envres.2017.02.028 · Cited by 36
The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulators
Kaistha, B. P., Krattenmacher, A., Fredebohm, J., Schmidt, H., Behrens, D., Widder, M., Hackert, T., Strobel, O., Hoheisel, J. D., Gress, T. M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19882 · Cited by 36
Obesity impacts the regulation of miR-10b and its targets in primary breast tumors
Meerson, A., Eliraz, Y., Yehuda, H., Knight, B., Crundwell, M. C., Ferguson, D., Lee, B. P., & Harries, L. W. (2019) · BMC Cancer · doi:10.1186/s12885-019-5300-6 · Cited by 36
Pratheeshkumar, P., & Kuttan, G. (2011) · Drug and Chemical Toxicology · doi:10.3109/01480545.2010.520017 · Cited by 36
Apostolidis, P. A., Lindsey, S. C., Miller, W. M., & Papoutsakis, E. T. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00028.2012 · Cited by 36
Brodowicz, T., Wiltschke, C., Kandioler-Eckersberger, D., Grunt, T. W., Rudas, M., Schneider, S., Hejna, M., Budinsky, A. C., & Zielinski, C. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690528 · Cited by 36
Quinacrine Inhibits Cell Growth and Induces Apoptosis in Human Gastric Cancer Cell Line SGC-7901
Wu, X., Wang, Y., Wang, H., Wang, Q., Wang, L., Miao, J., Cui, F., & Wang, J. (2012) · Current Therapeutic Research · doi:10.1016/j.curtheres.2012.02.003 · Cited by 35
Park, G. B., Song, H., Kim, Y. S., Sung, M., Ryu, J. W., Lee, H., Cho, D., Kim, D., Lee, W. J., & Hur, D. Y. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03111.x · Cited by 34
Chang, H., Chou, C., Lin, Y.-S., Shieh, P., Kuo, D., Jan, C., & Liang, W.-Z. (2015) · Tumor Biology · doi:10.1007/s13277-015-4286-1 · Cited by 35
Fatimah, S. S., Tan, G. C., Chua, K. H., Tan, A. E., & Hayati, A. R. (2012) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2012.03.021 · Cited by 35
Nitric oxide induces oral squamous cell carcinoma cells apoptosis with p53 accumulation
Shi-fang, Z., Tong, X.-Y., & Zhu, F. (2005) · Oral Oncology · doi:10.1016/j.oraloncology.2005.04.002 · Cited by 35
Investigation of simvastatin-induced apoptosis and cell cycle arrest in cancer stem cells of MCF-7
Afzali, M., Vatankhah, M., & Ostad, S. N. (2016) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.146127 · Cited by 35
New developments in the multi-site phosphorylation and integration of stress signalling at p53
Meek, D. W. (1998) · International Journal of Radiation Biology · doi:10.1080/095530098141005 · Cited by 35
Delayed activation of human microglial cells by high dose ionizing radiation
Chen, H., Chong, Z. Z., Toledo, S. M. D., Azzam, E. I., Elkabes, S., & Souayah, N. (2016) · Brain Research · doi:10.1016/j.brainres.2016.06.002 · Cited by 35
Limited role of N-terminal phosphoserine residues in the activation of transcription by p53
Jackson, M. W., Agarwal, M. K., Agarwal, M. L., Agarwal, A. M., Stanhope-Baker, P., Williams, B. R. G., & Stark, G. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207575 · Cited by 33
Self-citation
Metadata
- Authors
- Agarwal, M. L., Agarwal, A., Taylor, W. R., & Stark, G. R.
- Affiliations
- Cleveland Clinic (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1995-08-29
- Volume
- 92
- Issue
- 18
- Pages
- 8493-8497
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC41183
- OpenAlex
- W2016492849
- Semantic Scholar
- 0dec4b0f37cb7f12a6b4023ec829754468df3935
- Cited by
- 858
- References
- 30
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 13 · 2023: 22 · 2022: 12 · 2021: 18 · 2020: 24 · 2019: 21 · 2018: 22 · 2017: 40 · 2016: 29 · 2015: 28 · 2014: 33 · 2013: 25 · 2012: 25
- FWCI
- 17.64
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- p53, G2/M checkpoint, G1/S checkpoint, cell cycle arrest, p21, cyclin-dependent kinases, mimosine, DNA damage response
- MeSH terms
- Cell Cycle, Cell Division, Cell Line, Fibroblasts, Gene Expression Regulation, Humans, Genes, p53, Cyclins, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review